Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Apr. 17, 2023 | Jun. 30, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2022 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 001-51185 | ||
Entity Registrant Name | Golden Ally Lifetech Group, INC. | ||
Entity Central Index Key | 0001317833 | ||
Entity Tax Identification Number | 16-1732674 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Address, Address Line One | 901 S. Mopac Exp Building 1 | ||
Entity Address, Address Line Two | Suite 300 | ||
Entity Address, City or Town | Austin | ||
Entity Address, State or Province | TX | ||
Entity Address, Postal Zip Code | 78746 | ||
City Area Code | (512) | ||
Local Phone Number | 430-1553 | ||
Title of 12(b) Security | Common Stock, $0.00001 par value | ||
Trading Symbol | AQPW | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 9,748,500 | ||
Entity Common Stock, Shares Outstanding | 7,408,561,902 | ||
ICFR Auditor Attestation Flag | false | ||
Auditor Name | Spokane | ||
Auditor Location | Washington | ||
Auditor Firm ID | 5525 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Current | ||
Cash | $ 581,965 | $ 2,999,370 |
Prepaids | 40,952 | |
Loan receivable - related party | 1,000,000 | |
Total Current Assets | 1,622,917 | 2,999,370 |
Right of use asset | 97,899 | |
Total Assets | 1,720,816 | 2,999,370 |
Current Liabilities | ||
Accounts payable and accrued liabilities | 23,740 | |
Lease liabilities | 69,577 | |
Due to related parties | 5,000 | 5,000 |
Total Current liabilities | 98,317 | 5,000 |
Lease liability, net of current portion | 31,006 | |
Total Liabilities | 129,323 | 5,000 |
Stockholders’ Equity | ||
Convertible Series A Preferred Stock, par value $0.00001: 1,000,000,000 authorized; 1,000,000,000 and 1,000,000,000 outstanding | 10,000 | 10,000 |
Common Stock, par value $0.00001; 10,000,000,000 authorized; 7,403,561,902, and 8,496,061,902 outstanding | 74,036 | 84,961 |
Subscription receivable | (5,042,060) | |
Additional paid-in capital | 7,636,614 | 7,999,039 |
Accumulated deficit | (6,129,157) | (57,570) |
Total Stockholders’ Equity | 1,591,493 | 2,994,370 |
Total Liabilities and Stockholders’ Equity | $ 1,720,816 | $ 2,999,370 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Common stock, par value | $ 0.00001 | $ 0.00001 |
Common stock, shares authorized | 10,000,000,000 | 10,000,000,000 |
Common stock, shares outstanding | 7,403,561,902 | 8,496,061,902 |
Convertible Series A Preferred Stock [Member] | ||
Preferred stock, par value | $ 0.00001 | $ 0.00001 |
Preferred stock, shares authorized | 1,000,000,000 | 1,000,000,000 |
Preferred Stock, shares outstanding | 1,000,000,000 | 1,000,000,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Expenses | ||
General and administrative | $ 274,379 | $ 70 |
Professional fees | 3,940,389 | 57,500 |
Research and development | 98,450 | |
Wages and salaries | 1,758,369 | |
Total Operating Expenses | 6,071,587 | 57,570 |
Net operating loss | (6,071,587) | (57,570) |
Income tax | ||
Net Loss | $ (6,071,587) | $ (57,570) |
Loss per Common Share | $ 0 | $ 0 |
Weighted Average Common Shares Outstanding | 8,490,582,450 | 9,480,000,000 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - 12 months ended Dec. 31, 2022 - USD ($) | Previously Reported [Member] Preferred Stock [Member] Series A Preferred Stock [Member] | Previously Reported [Member] Common Stock [Member] | Previously Reported [Member] Common Stock For Future Issuance [Member] | Previously Reported [Member] Additional Paid-in Capital [Member] | Previously Reported [Member] Subscriptions Receivable [Member] | Previously Reported [Member] Retained Earnings [Member] | Previously Reported [Member] | Preferred Stock [Member] Series A Preferred Stock [Member] | Common Stock [Member] | Common Stock For Future Issuance [Member] | Additional Paid-in Capital [Member] | Subscriptions Receivable [Member] | Retained Earnings [Member] | Total |
Balance at Dec. 31, 2021 | $ 5,000 | $ 20,536 | $ 164 | $ 7,985,177 | $ (8,029,435) | $ (18,558) | $ 10,000 | $ 84,961 | $ 7,999,039 | $ (5,042,060) | $ (57,570) | $ 2,994,370 | ||
Balance, shares at Dec. 31, 2021 | 5,000,000 | 20,535,982 | 1,000,000,000 | 8,496,061,902 | ||||||||||
Shares issued persuant to share exchange | $ 9,950 | $ 84,755 | 7,999,200 | (5,042,060) | 3,051,845 | |||||||||
Shares issued persuant to share exchange, shares | 8,475,525,920 | 8,475,525,920 | ||||||||||||
Recapitalization after share exchange and par value change | $ (4,950) | $ (20,330) | (164) | (7,985,338) | $ 7,971,865 | (38,917) | ||||||||
Recapitalization after share exchange and par value change, shares | 995,000,000 | |||||||||||||
Net loss | (6,071,587) | (6,071,587) | ||||||||||||
Stock subscription received | 5,042,060 | 5,042,060 | ||||||||||||
Share exchange (reverse merger) | (373,350) | (373,350) | ||||||||||||
Shares cancelled | $ (10,375) | 10,375 | ||||||||||||
Shares cancelled, shares | (1,037,500,000) | |||||||||||||
Balance at Dec. 31, 2022 | $ 10,000 | $ 74,586 | $ 7,636,064 | $ (6,129,157) | $ 1,591,493 | |||||||||
Balance, shares at Dec. 31, 2022 | 1,000,000,000 | 7,458,561,902 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (6,071,587) | $ (57,570) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization of ROU asset | 40,311 | |
Payment of lease lability | (37,628) | |
Prepaids | (40,952) | |
Accounts payable and accrued liabilities and other | 23,740 | |
Net cash used in Operating Activities | (6,086,115) | (57,570) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from receipt of subscription receivable | 5,042,060 | |
Merger consideration paid in cash | (373,350) | |
Proceeds from issuance of common shares | 3,051,940 | |
Net cash provided by Financing Activities | 4,668,710 | 3,051,940 |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Due to related party | 5,000 | |
Loan receivable - related party | (1,000,000) | |
Net cash provided by (used) in Investing Activities | (1,000,000) | 5,000 |
Inflow of Cash | (2,417,405) | 2,999,370 |
Cash - Beginning of period | 2,999,370 | |
Cash - End of period | 581,965 | 2,999,370 |
SUPPLEMENTAL CASH FLOW INFORMATION: | ||
Cash paid for income taxes | ||
Cash paid for interest | ||
NON CASH INVESTING AND FINANCING ACTIVITIES: | ||
Share cancellation | $ 10,875 |
BUSINESS
BUSINESS | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
BUSINESS | NOTE 1 – BUSINESS Golden Ally Lifetech Group Inc. (“Golden Ally”) is a Delaware corporation incorporated on December 1, 2020, and operates primarily out of Austin, Texas. Golden Ally is a start-up company focusing on a unique product offering. Golden Ally activities to date have focused on the development and exploration of water filtration technology and consumer products with Aquaporin (“AQP”) Active Water. Golden Ally has been working with field experts and research institutions to apply and explore the ability to enhance water filtration for improved body cell absorption in commercialized water products. On April 06, 2022, Golden Ally closed on the Share Purchase and Exchange Agreement (“SPA”) with Signet International Holdings, Inc. (“Signet”), a Delaware corporation formed on February 2, 2005, and the Signet Controlling Shareholders. Under generally accepted accounting principles, the acquisition by Signet of Golden Ally is considered to be a capital transaction in substance, rather than a business combination. That is, the acquisition is equivalent to the acquisition by Golden Ally of Signet with the issuance of stock by Golden Ally for the net assets of Signet. This transaction is reflected as a recapitalization and is accounted for as a change in capital structure. Accordingly, the accounting for the acquisition is identical to that resulting from a reverse acquisition. Under reverse merger accounting, the comparative historical financial statements of Signet, as the legal acquirer, are those of the accounting acquirer, Golden Ally. Accordingly, Golden Ally’s financial statements prior to the closing of the reverse acquisition, reflect only the business of Golden Ally, as a result, the prior periods have been retrospectively adjusted from the earliest presented period. Under the SPA, the Controlling Shareholders of the Signet agreed to sell to the Company their capital stock of the Company, consisting of 5,000,000 50,000,000 4,474,080 375,000 In March 2022 Signet’s Board of Directors approved, among other things, an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, subject to stockholder approval. Stockholder approval was obtained through written consent. Upon approval of all regulating authorities, Signet’s name was changed from “Signet International Holdings, Inc.” to “Golden Ally Lifetech Group, Inc.” |
GOING CONCERN
GOING CONCERN | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
GOING CONCERN | NOTE 2 – GOING CONCERN The financial statements have been prepared on a going concern basis which assumes Golden Ally will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. Golden Ally has not yet established a source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. As reflected in the accompanying financial statements, Golden Ally had a net loss of $ 6,071,587 6,086,115 6,129,157 In order to continue as a going concern, Golden Ally will need, among other things, additional capital resources. Management’s plan is to obtain such resources for Golden Ally by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking third party equity and/or debt financing. Management has held preliminary discussions with potential investors to secure significant capital for Golden Ally in 2023. Management is confident that the diversified options for financing available to Golden Ally in 2023, along with support from significant shareholders, will allow it to achieve its objectives and satisfy its capital requirements. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should Golden Ally be unable to continue as a going concern. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Pursuant to the SPA, the Business Combination was accounted for as a recapitalization in accordance with US GAAP. Under this method of accounting, of Signet International Holdings, Inc., was treated as the acquired company and Golden Ally Lifetech Group, Inc., was treated as the acquirer for financial statement reporting purposes. Golden Ally Lifetech Group, Inc. was determined to be the accounting acquirer based on evaluation of the following facts and circumstances: ● Golden Ally Lifetech Group, Inc., through their ownership of the Convertible Series A Preferred stock and Common Stock, has a 77% ● Golden Ally Lifetech Group, Inc., selected all of the new board of directors of Signet; ● Golden Ally Lifetech Group, Inc., senior management is the senior management of Signet; and ● Golden Ally Lifetech Group, Inc., is the larger entity based on historical operating activity. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure at the date of the financial statements. Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for continued reasonableness. Actual results and outcomes may differ from management’s estimates and assumptions. Cash and cash equivalents For purposes of the statement of cash flows, Golden Ally considers all highly liquid instruments purchased with an original maturity of three months or less to be cash. As of December 31, 2022, and December 31, 2021, Golden Ally had cash of $ 581,965 2,999,370 Concentrations of Credit Risk Golden Ally maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Golden Ally continually monitors its banking relationships and consequently has not experienced any losses in its accounts. Management believes Golden Ally is not exposed to any significant credit risk on cash. Deferred Income Tax and Valuation Allowance The Company accounts for income taxes under ASC 740 “Income Taxes.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. Research and Development (“R&D”) R&D expenses consist primarily of costs related to product development, personnel expenses, and other R&D expenses. Product development relates to the Company’s creation and development of consumer product. Personnel expenses relate primarily to salaries and benefits. R&D expenditures are charged to operations as incurred. Loans receivable Loans receivable due from related parties are stated at historical cost and reviewed periodically for collectability. Loss per Share Loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Golden Ally had no dilutive instruments outstanding during the periods presented. Recent Accounting Pronouncements Golden Ally has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and Golden Ally does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. Reclassification In prior filings, the Company had classified and recognized goodwill associated with the acquisition of Signet by Golden Ally. As of December 31, 2022, these financial statements have reflected the classification of the reverse merger with a public shell with no |
PREPAID EXPENSE
PREPAID EXPENSE | 12 Months Ended |
Dec. 31, 2022 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
PREPAID EXPENSE | NOTE 4 – PREPAID EXPENSE During the year ended December 31, 2022 the Company entered into several service agreements with terms of twelve months or greater. As of December 31, 2022 the Company had prepaid expenses of $ 40,952 |
LOAN RECEIVABLE _ RELATED PARTY
LOAN RECEIVABLE – RELATED PARTY | 12 Months Ended |
Dec. 31, 2022 | |
Loan Receivable Related Party | |
LOAN RECEIVABLE – RELATED PARTY | NOTE 5 – LOAN RECEIVABLE – RELATED PARTY On May 15, 2022, the Company entered into a loan agreement whereby the Company loaned $ 1,000,000 |
LEASES
LEASES | 12 Months Ended |
Dec. 31, 2022 | |
Leases | |
LEASES | NOTE 6 - LEASES During the year ended December 31, 2022, the Company entered into a lease for a location in California. The lease commenced on June 1, 2022 and is for a period of two years 138,210 40,311 6,472 44,100 97,899 100,583 SCHEDULE OF PRINCIPAL LEASE PAYMENTS Lease Liability - December 31, 2022 $ 97,899 Less imputed interest 6,517 Minimum payments 104,416 |
INVESTMENT _ RELATED PARTY, AND
INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION | 12 Months Ended |
Dec. 31, 2022 | |
Investments, All Other Investments [Abstract] | |
INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION | NOTE 7 – INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION On December 1, 2021, the Company entered into an agreement to purchase 20% 2,000,000 2,000,000 On March 7, 2022, the Company entered a recission agreement with Asia Hybrid, and a related party, whereby the original agreement between the Company and Asia Hybrid was rescinded effective December 1, 2021, and both party’s obligations of the agreement were terminated and the $ 2,000,000 |
CAPITAL STOCK
CAPITAL STOCK | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
CAPITAL STOCK | NOTE 8 – CAPITAL STOCK Common Stock During the year ended December 31, 2022, Golden Ally received $ 5,042,060 During the year ended December 31 2022, the Company issued 8,475,525,920 On November 21, 2022, the Company cancelled 1,092,500,000 The authorized capital stock consists of 10,000,000,000 0.00001 7,403,561,902 8,496,061,902 Preferred stock On April 6, 2022, the Company amended the authorized shares of capital preferred stock to 1,000,000,000 0.00001 Preferred stock have a 10:1 voting right and are convertible to common stock at a ratio of 1:1. On April 6, 2022, the Company issued 995,000,000 There were 1,000,000,000 1,000,000,000 On July 8, 2022, the Company merged its sole subsidiary into the Company. Only the Company exists from this date. |
RELATED PARTIES
RELATED PARTIES | 12 Months Ended |
Dec. 31, 2022 | |
Related Party Transactions [Abstract] | |
RELATED PARTIES | NOTE 9 – RELATED PARTIES During the year ended December 31, 2021, a related party paid expenses on behalf of the Company of $ 5,000 5,000 During the year ended December 31, 2022 and 2021, the Company paid $ 1,758,369 nil During the year ended December 31, 2022, Golden Ally entered into an agreement with a company owned by a related party to develop and implement marketing strategies for Golden Ally’s products. Golden Ally paid $ 2,900,000 See Note 5 for Loan Receivable – Related Party. |
COMMITMENTS
COMMITMENTS | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS | NOTE 10 – COMMITMENTS Operating lease During the year ended December 31, 2022, the Company entered into an agreement for office space in Texas. The agreement term is from January 19, 2022, to January 31, 2023 332 During the year ended December 31, 2022, the Company entered into a lease for a location in California. The term of the lease was four months ending on May 31, 2022 5,970 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 11 – SUBSEQUENT EVENTS In February 2023, the Company issued 5,000,000 |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Pursuant to the SPA, the Business Combination was accounted for as a recapitalization in accordance with US GAAP. Under this method of accounting, of Signet International Holdings, Inc., was treated as the acquired company and Golden Ally Lifetech Group, Inc., was treated as the acquirer for financial statement reporting purposes. Golden Ally Lifetech Group, Inc. was determined to be the accounting acquirer based on evaluation of the following facts and circumstances: ● Golden Ally Lifetech Group, Inc., through their ownership of the Convertible Series A Preferred stock and Common Stock, has a 77% ● Golden Ally Lifetech Group, Inc., selected all of the new board of directors of Signet; ● Golden Ally Lifetech Group, Inc., senior management is the senior management of Signet; and ● Golden Ally Lifetech Group, Inc., is the larger entity based on historical operating activity. |
Use of Estimates | Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses, and disclosure at the date of the financial statements. Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for continued reasonableness. Actual results and outcomes may differ from management’s estimates and assumptions. |
Cash and cash equivalents | Cash and cash equivalents For purposes of the statement of cash flows, Golden Ally considers all highly liquid instruments purchased with an original maturity of three months or less to be cash. As of December 31, 2022, and December 31, 2021, Golden Ally had cash of $ 581,965 2,999,370 |
Concentrations of Credit Risk | Concentrations of Credit Risk Golden Ally maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Golden Ally continually monitors its banking relationships and consequently has not experienced any losses in its accounts. Management believes Golden Ally is not exposed to any significant credit risk on cash. |
Deferred Income Tax and Valuation Allowance | Deferred Income Tax and Valuation Allowance The Company accounts for income taxes under ASC 740 “Income Taxes.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. |
Research and Development (“R&D”) | Research and Development (“R&D”) R&D expenses consist primarily of costs related to product development, personnel expenses, and other R&D expenses. Product development relates to the Company’s creation and development of consumer product. Personnel expenses relate primarily to salaries and benefits. R&D expenditures are charged to operations as incurred. |
Loans receivable | Loans receivable Loans receivable due from related parties are stated at historical cost and reviewed periodically for collectability. |
Loss per Share | Loss per Share Loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Golden Ally had no dilutive instruments outstanding during the periods presented. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Golden Ally has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and Golden Ally does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Reclassification | Reclassification In prior filings, the Company had classified and recognized goodwill associated with the acquisition of Signet by Golden Ally. As of December 31, 2022, these financial statements have reflected the classification of the reverse merger with a public shell with no |
LEASES (Tables)
LEASES (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases | |
SCHEDULE OF PRINCIPAL LEASE PAYMENTS | SCHEDULE OF PRINCIPAL LEASE PAYMENTS Lease Liability - December 31, 2022 $ 97,899 Less imputed interest 6,517 Minimum payments 104,416 |
BUSINESS (Details Narrative)
BUSINESS (Details Narrative) - Share Purchase and Exchange Agreement [Member] | 12 Months Ended |
Dec. 31, 2022 USD ($) shares | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Number of shares issued upon conversion of convertible securities, value | $ | $ 375,000 |
Common Stock [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Number of shares convertible into common shares | 50,000,000 |
Number of shares issued upon conversion of convertible securities | 4,474,080 |
Series A Convertible Super Preferred Stock [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Number of shares convertible into common shares | 5,000,000 |
GOING CONCERN (Details Narrativ
GOING CONCERN (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Net Loss | $ 6,071,587 | $ 57,570 |
Net cash used in operating activities | 6,086,115 | 57,570 |
Accumulated deficit | $ 6,129,157 | $ 57,570 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | ||
Percentage of voting interest | 77% | |
Cash | $ 581,965 | $ 2,999,370 |
Goodwill | $ 0 |
PREPAID EXPENSE (Details Narrat
PREPAID EXPENSE (Details Narrative) | Dec. 31, 2022 USD ($) |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Prepaid expense | $ 40,952 |
LOAN RECEIVABLE _ RELATED PAR_2
LOAN RECEIVABLE – RELATED PARTY (Details Narrative) | May 15, 2022 USD ($) |
Loan Receivable Related Party | |
Loan receivable - related party | $ 1,000,000 |
SCHEDULE OF PRINCIPAL LEASE PAY
SCHEDULE OF PRINCIPAL LEASE PAYMENTS (Details) | Dec. 31, 2022 USD ($) |
Leases | |
Lease Liability - December 31, 2022 | $ 97,899 |
Less imputed interest | 6,517 |
Minimum payments | $ 104,416 |
LEASES (Details Narrative)
LEASES (Details Narrative) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Jun. 01, 2022 | |
Leases | |||
Lease term | 2 years | ||
Right of use lease liability | $ 100,583 | $ 138,210 | |
Income recognized through lease income | 40,311 | ||
Lease interest expense | 6,472 | ||
Lease cost | 44,100 | ||
Right of use lease asset | $ 97,899 |
INVESTMENT _ RELATED PARTY, A_2
INVESTMENT – RELATED PARTY, AND ITS SUBSEQUENT RECISSION (Details Narrative) - Asia Hybrid Cryptocurrency Limited [Member] - USD ($) | Mar. 07, 2022 | Dec. 01, 2021 |
Investment percentage | 20% | |
Payments to acquire investments | $ 2,000,000 | $ 2,000,000 |
CAPITAL STOCK (Details Narrativ
CAPITAL STOCK (Details Narrative) - USD ($) | 12 Months Ended | |||
Nov. 21, 2022 | Apr. 06, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Stock subscriptions | $ 5,042,060 | |||
Capital stock, shares authorized | 10,000,000,000 | 10,000,000,000 | ||
Capital stock, par value | $ 0.00001 | $ 0.00001 | ||
Capital stock, shares outstanding | 7,403,561,902 | 8,496,061,902 | ||
Preferred stock shares authorized | 1,000,000,000 | |||
Preferred stock, par value | $ 0.00001 | |||
Preferred stock voting rights | Preferred stock have a 10:1 voting right and are convertible to common stock at a ratio of 1:1. | |||
Series A Preferred Stock [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Preferred stock, shares issued | 995,000,000 | 1,000,000,000 | 1,000,000,000 | |
Preferred stock, shares outstanding | 1,000,000,000 | 1,000,000,000 | ||
Common Stock [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Stock issued during period | 8,475,525,920 | |||
Common stock, cancelled, shares | 1,092,500,000 | (1,037,500,000) |
RELATED PARTIES (Details Narrat
RELATED PARTIES (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Related Party Transactions [Abstract] | ||
Due to related party | $ 5,000 | $ 5,000 |
Wages and salaries to related parties | 1,758,369 | |
Related party expense | $ 2,900,000 |
COMMITMENTS (Details Narrative)
COMMITMENTS (Details Narrative) | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
TEXAS | |
Product Liability Contingency [Line Items] | |
Lease term | January 19, 2022, to January 31, 2023 |
Rent per month | $ 332 |
CANADA | |
Product Liability Contingency [Line Items] | |
Lease term | May 31, 2022 |
Rent per month | $ 5,970 |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) | Feb. 28, 2023 shares |
Subsequent Event [Member] | |
Subsequent Event [Line Items] | |
Common stock, shares issued | 5,000,000 |